Back
Corporate News
Ind-Swift Laboratories proposes warrant issue to fund facility expansion and subsidiary investment
29-Jul-2026, 08:06
Ind-Swift Laboratories Limited notified the BSE Limited and National Stock Exchange of India Limited of a corrigendum to the notice of its Extra Ordinary General Meeting scheduled for August 5, 2026, regarding a proposed preferential issue of 70,00,000 fully convertible warrants to a promoter group entity. The changes, stemming from observations by the BSE and NSE, detail the intended use of proceeds, including expansion of existing manufacturing facilities at Jawaharpur, Derabassi (PB), and Jammu (J&K), research and development, technology upgrades, and an investment in its subsidiary, ISLL Middle East LLC -FZ, Dubai, with a tentative timeline for utilization ranging from December 2028 to December 2029.
Ind-Swift Laboratories Limited notified the BSE Limited and National Stock Exchange of India Limited of a corrigendum to the notice of its Extra Ordinary General Meeting scheduled for August 5, 2026, regarding a proposed preferential issue of 70,00,000 fully convertible warrants to a promoter group entity. The changes, stemming from observations by the BSE and NSE, detail the intended use of proceeds, including expansion of existing manufacturing facilities at Jawaharpur, Derabassi (PB), and Jammu (J&K), research and development, technology upgrades, and an investment in its subsidiary, ISLL Middle East LLC -FZ, Dubai, with a tentative timeline for utilization ranging from December 2028 to December 2029.